Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4553791000168112 | ofatumumab 20 mg / 0.4 mL injection, 0.4 mL pen device (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4553801000168113 | ofatumumab 20 mg/0.4 mL injection, pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ofatumumab 20 mg/0.4 mL injection, pen device | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| ofatumumab 20 mg/0.4 mL injection, pen device | Is a | ofatumumab | true | Inferred relationship | Some | ||
| ofatumumab 20 mg/0.4 mL injection, pen device | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| ofatumumab 20 mg/0.4 mL injection, pen device | has Australian BoSS | ofatumumab | true | Inferred relationship | Some | 883734912 | |
| ofatumumab 20 mg/0.4 mL injection, pen device | has intended active ingredient | ofatumumab | true | Inferred relationship | Some | 883734912 | |
| ofatumumab 20 mg/0.4 mL injection, pen device | has unit of use | pen device | true | Inferred relationship | Some | 1407179416 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device | Is a | True | ofatumumab 20 mg/0.4 mL injection, pen device | Inferred relationship | Some | |
| ofatumumab 20 mg/0.4 mL injection, 0.4 mL pen device | has MPUU | True | ofatumumab 20 mg/0.4 mL injection, pen device | Inferred relationship | Some | 804874301 |
Reference Sets
Medicinal product unit of use reference set
FHIR